The GOOD news on "PD1" is more than just good. >>>I've never seen something as black and white," said Rafick Sékaly, a professor at Canada's Université de Montréal and a leader of the team whose study was published today in Nature Medicine.<<<
>>>A third scientific team, led by Richard Koup, chief of the immunology laboratory at the National Institutes of Health's Vaccine Research Center, also has been researching PD-1 in HIV. That study is scheduled to be published Sept. 5 in the online edition of the Journal of Experimental Medicine. Dr. Koup's team found that the interaction between PD-1 and its ligand appears to cause CD8 cells to die, not merely to stop functioning.<<<
Now imagine if this works in trials. This alone will be worth billions in government and United Nations subsidized contracts!!!!!!!!"
Market Data 
Markets 
AI
